Dr. Harsha Vardhan Reddy G

Consultant Interventional Gastroenterologist & Hepatologist

MD (Int. Med), DM (Med. Gastro)

Registration Number: TSMC/FMR/14877

OP Timings

Monday	Tuesday	Wednesday	Thursday	Friday	Saturday	Sunday
9:00am - 5:30pm	9:00am - 5:30pm	9:00am - 5:30pm	9:00am - 5:30pm	9:00am - 5:30pm	9:00am - 5:30pm	Not Available

Profile

Dr. Harsha Vardhan Reddy is a highly skilled gastroenterologist in Hyderabad, specializing in medical gastroenterology and hepatology.

With over 13 years of experience, he is dedicated to providing comprehensive digestive and liver care.

He is an integral part of KAGE – KIMS Advanced Gastroenterology and Endoscopy at KIMS Hospitals, Secunderabad, where he offers advanced diagnosis and treatment for a wide range of gastrointestinal disorders.

Dr. Reddy holds an MBBS from Rajiv Gandhi University of Health Sciences (2011), an MD in General Medicine (2015), and a DM in Gastroenterology from Kaloji Narayana Rao University of Health Sciences (2020).

His expertise includes treating conditions such as GERD, IBS, IBD, fatty liver disease, hepatitis, liver cirrhosis, and pancreatic disorders.

Recognized as one of the best gastroenterologists in Hyderabad, Dr. Reddy is proficient in advanced endoscopic procedures, including UGI endoscopy, colonoscopy, and ERCP, ensuring minimally invasive, high-precision treatments for digestive and liver diseases.

As a key member of KAGE – KIMS Advanced Gastroenterology and Endoscopy, Dr. Reddy is committed to delivering state-of-the-art treatments at one of the leading gastro hospitals in Hyderabad.

His expertise, patient-focused approach, and dedication to clinical excellence make him the go-to gastro doctor in Hyderabad.

For expert diagnosis and treatment of gastrointestinal and liver conditions, consult Dr. Harsha Vardhan Reddy at KIMS Hospitals, Secunderabad today.

Advanced Therapeutic Endoscopy Expertise

Hepato-Pancreato-Biliary Endoscopic Interventions

Expertise in advanced ERCP for complex hepatobiliary and pancreatic diseases.
Specialized in therapeutic interventions for malignant biliary obstruction including hilar cholangiocarcinoma and pancreatic cancer.
Proficiency in complex pancreatic duct interventions, including pancreatic ductal stenting and pancreatic necrosectomy.
killed in biliary and pancreatic stone extraction using advanced lithotripsy techniques.

Endoscopic Management of Pancreatic Diseases

Advanced skills in EUS-guided pancreatic fluid collection drainage and necrosectomy.
Expertise in EUS-guided Fine Needle Aspiration (FNA) and Fine Needle Biopsy (FNB) for pancreatic cysts and solid masses.
Proficiency in EUS-guided Cysto-gastrostomy and Endoscopic Transmural Drainage.
Pioneering EUS-guided Radiofrequency Ablation (RFA) for pancreatic cyst ablation and neuroendocrine tumors.

Complicated ERCP

Skilled in advanced ERCP techniques including metal stent placement and cholangioscopy
Experience in complex biliary and pancreatic strictures, malignant obstruction management, and bile leak interventions.
Expertise in hepaticogastrostomy and choledochoduodenostomy for biliary drainage.

Clinical Experience

Performed over 10,000 Upper GI Endoscopies and 3,000+ Colonoscopies including complex diagnostic procedures.
Specialized in managing complicated hepatobiliary and pancreatic cases with multidisciplinary approaches.
Led high-risk therapeutic endoscopy cases with a focus on patient safety and outcomes.
Active involvement in liver transplant patient care and post-operative management.

Publications & Research Papers

CD4 count in patients with HIV and Tuberculous Meningitis coinfection - A perfect surrogate marker of disease severity? Kumar N M, Ram S Kaulgud, Harshavardhan Reddy, Mallikarjuna Swamy. DOI: https://doi.org/10.7439/ijbr.v4i10.380

Co-investigator in clinical trials at Osmania Medical College in the Department of Medical Gastroenterology:

1. Multicentre open-label prospective Phase IV interventional study in adult patients to evaluate the safety & efficacy of MyHep LVIRTM (ledipasvir/sofosbuvir fixed-dose combination) in HCV genotype 1 infection & the combination of MyHep TM (sofosbuvir) & My Dekla TM (daclatasvir) in HCV genotype 3 infections.

2. Multicentre open-label single-arm prospective Phase IV study to evaluate the safety & efficacy of My HEP All (sofosbuvir/velpatasvir fixed-dose combination) in Indian adult patients with Hepatitis C virus infection.

3. A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Multicentre Study to Evaluate the Efficacy, Safety, and Tolerability of TRC160334 as an Add-on to Mesalamine in Subjects with Mild to Moderately Active Ulcerative Colitis.

Participated in various national & international conferences during DM residency.